Cancer in North Cyprus: 1. Current Status, An Overview

dc.contributor.authorDjamgoz, Mustafa B. A.
dc.contributor.authorAkun, Ertan
dc.contributor.authorArslan, Beste
dc.contributor.authorNazif, Sultan
dc.contributor.authorBesler, H. Tanju
dc.contributor.authorRizaner, Nahit
dc.date.accessioned2026-02-06T18:21:51Z
dc.date.issued2017
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractThis is the first of a two-part review dealing with cancer issues in North Cyprus (NC). Here we give an account of what is known about the cancer status of the island, which has been debated quite intensely over the years. From several independent reports, it is concluded that the epidemiology of cancer in NC has been steady around 200-230 per 100,000 for more than 20 years. This level is in line with the rest of Europe. Nevertheless, there are some potentially worrying signs. First, the age-standardized rate of some cancers (lung, skin, and liver) appears higher. Second, the average age of incidence is lower for breast and skin cancer in NC than in the rest of Europe. Relevant environmental factors of current interest that could contribute to these issues include the environmental levels of potentially carcinogenic heavy metals (e.g., arsenic, cadmium and lead) and the levels of vitamin D in the population. The particular case of the copper mines in the Lefke region is also covered. We conclude that (i) the overall cancer status of NC is broadly comparable to the rest of Europe, (ii) continuous monitoring of epidemiology is necessary, and (iii) research is needed into the possible cause(s) of cancer, especially environmental factors.
dc.description.sponsorshipCancer Research Foundation (CRF)/Kanser Arastirma Vakfi (KAV); United Nations Office for Project Services (UNOPS); European Union; TUBITAK in the TRNC; Pro Cancer Research Fund (PCRF) in the UK
dc.description.sponsorshipThis research is supported by the Cancer Research Foundation (CRF)/Kanser Arastirma Vakfi (KAV), the United Nations Office for Project Services (UNOPS), the European Union and TUBITAK in the TRNC, and by the Pro Cancer Research Fund (PCRF) in the UK.
dc.identifier.doi10.5152/cjms.2017.144
dc.identifier.endpage12
dc.identifier.issn2149-7893
dc.identifier.issn2536-507X
dc.identifier.issue1
dc.identifier.scopusqualityN/A
dc.identifier.startpage9
dc.identifier.urihttps://doi.org/10.5152/cjms.2017.144
dc.identifier.urihttps://hdl.handle.net/11129/9495
dc.identifier.volume2
dc.identifier.wosWOS:000414804700004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAves Press Ltd
dc.relation.ispartofCyprus Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectCancer
dc.subjectNorth Cyprus
dc.subjectepidemiology
dc.subjectheavy metal
dc.subjectvitamin D
dc.titleCancer in North Cyprus: 1. Current Status, An Overview
dc.typeReview Article

Files